![]() |
![]() |
![]() |
![]() |
ABI = ankle–brachial index; ABPM = ambulatory blood pressure monitoring; ACEI = angiotensin-converting enzyme inhibitor; b.i.d. = twice daily (bis in die); b.p.m. = beats per minute; CABG = coronary artery bypass graft; CAC = coronary artery calcium; CAD = coronary artery disease; CKD = chronic kidney disease; CRT = cardiac resynchronization therapy; CRT-D = cardiac resynchronization therapy with an implantable defibrillator; CT = computed tomography; CV = cardiovascular; CVD = cardiovascular disease; DAPT = dual antiplatelet therapy; DM = diabetes mellitus; DPP4 = dipeptidyl peptidase-4; ECG = electrocardiogram; eGFR = estimated glomerular filtration rate; GLP1-RA = glucagon-like peptide-1 receptor agonist; HF = heart failure; HFrEF = heart failure with reduced ejection fraction; ICD = implantable cardioverter defibrillator; LEAD = lower extremity artery disease; MRA = mineralocorticoid receptor agonist; o.d. = once daily (omni die); PAD = peripheral arterial disease; PCSK9 = proprotein convertase subtilisin/kexin type 9; RAAS = renin–angiotensin–aldosterone system; SGLT2 = sodium-glucose co-transporter-2; T1DM = type 1 diabetes mellitus T2DM = type 2 diabetes mellitus.
![]() |
![]() |
![]() |
![]() |
ABI = ankle–brachial index; ABPM = ambulatory blood pressure monitoring; ACEI = angiotensin-converting enzyme inhibitor; b.i.d. = twice daily (bis in die); b.p.m. = beats per minute; CABG = coronary artery bypass graft; CAC = coronary artery calcium; CAD = coronary artery disease; CKD = chronic kidney disease; CRT = cardiac resynchronization therapy; CRT-D = cardiac resynchronization therapy with an implantable defibrillator; CT = computed tomography; CV = cardiovascular; CVD = cardiovascular disease; DAPT = dual antiplatelet therapy; DM = diabetes mellitus; DPP4 = dipeptidyl peptidase-4; ECG = electrocardiogram; eGFR = estimated glomerular filtration rate; GLP1-RA = glucagon-like peptide-1 receptor agonist; HF = heart failure; HFrEF = heart failure with reduced ejection fraction; ICD = implantable cardioverter defibrillator; LEAD = lower extremity artery disease; MRA = mineralocorticoid receptor agonist; o.d. = once daily (omni die); PAD = peripheral arterial disease; PCSK9 = proprotein convertase subtilisin/kexin type 9; RAAS = renin–angiotensin–aldosterone system; SGLT2 = sodium-glucose co-transporter-2; T1DM = type 1 diabetes mellitus T2DM = type 2 diabetes mellitus.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.